Diabetes Mellitus, Type 2

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Zagreb, Croatia
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Bialystok, Poland
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Rzeszów, Poland
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Bucharest, Romania

• Oregon Health & Science University General Clinical Research Center — Portland, Oregon, United States

• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Gilbert, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States

Not specified

• University of Pittsburgh School of Medicine — Pittsburgh, Pennsylvania, United States

• The Affiliated Hospital to Changchun University of Chinese Medicine — Changchun, China
• Jilin Hospital of Integrated Traditional and Western Medicine — Changchun, China
• Shanghai Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine — Shanghai, China
• The Affiliated Hospital to Liaoning University of Traditional Chinese Medicine — Shenyang, China

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Purkersdorf, Austria
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Beroun, Czechia
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Bad Homburg, Germany
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Athens, Greece

• Thomas J. Stephens & Associates — Colorado Springs, Colorado, United States
• TKL Research, Inc. — Carlstadt, New Jersey, United States
• TKL Research, Inc — Paramus, New Jersey, United States
• TKL Research, Inc. — Ramsey, New Jersey, United States

• Profil Institut für Stoffwechselforschung GmbH — Neuss, Germany

• University of Washington — Seattle, Washington, United States